SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) today announced success in the Company’s initial product launch for the MicroThermX Microwave Ablation System (MTX-180). BSD’s initial product launch has been focused on placement of a select number of systems with pivotal, high-profile, interventional oncology, key opinion leaders. BSD has successfully placed three of these systems and will shortly place a fourth system.